ASTEC — Astec Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹25.52bn
- IN₹30.42bn
- IN₹4.58bn
Annual cashflow statement for Astec Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 614 | 891 | 1,211 | 349 | -617 |
| Depreciation | |||||
| Non-Cash Items | 143 | 34.4 | 73.7 | 169 | 272 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 696 | -1,264 | -1,393 | -108 | 85.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,684 | -82 | 236 | 747 | 102 |
| Capital Expenditures | -453 | -1,025 | -1,040 | -1,173 | -1,355 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -285 | 294 | 1.12 | 47.5 | 3.17 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -738 | -731 | -1,039 | -1,125 | -1,352 |
| Financing Cash Flow Items | -129 | -47.5 | -89.1 | -201 | 268 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -945 | 813 | 805 | 378 | 1,250 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.958 | 0.308 | 2.16 | -0.811 | -0.019 |